Angiotensin II receptor type 1 blockade regulates Klotho expression to induce TSC2-deficient cell death
Shikshya Shrestha(Brigham and Women's Hospital), Souheil El‐Chemaly(AVEO Oncology (United States)), Jewel Imani(Brigham and Women's Hospital), Mark A. Perrella(Brigham and Women's Hospital), Elio Adib(Dana-Farber Brigham Cancer Center), Elizabeth P. Henske(Brigham and Women's Hospital), D. Tassew(Brigham and Women's Hospital), Anthony M. Lamattina(Harvard University), Carmen Priolo(Brigham and Women's Hospital), Dean J. Aguiar(TSC Alliance)
Cited by 4
Related Papers
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|860
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
|Proceedings of the National Academy of Sciences|1994|806
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
|Circulation Research|1993|776
Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP.
|Proceedings of the National Academy of Sciences|1995|710
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
|Cancer Cell|2017|656